Currently, clinical treatment mainly focuses on improving lifestyle, controlling hemodynamics (e.g., antihypertensive treatment), and improving metabolic disorders (e.g., glucose-lowering therapy and lipid-lowering therapy); the renin-angiotensin-aldosterone system is critical to the development of DN. Here, REN is linked to metabolic disease.